Fresenius SE: 36% Share Decline Reveals Long-Term Healthcare RisksFresenius SE’s €70‑to‑€45 plunge shows how regulatory, tech, and competitive forces can erode long‑term healthcare stock value – 36% loss in 12 years.FRESENIUS SE & CO KGAA Health Care Health Care Equipment & Services AI generated Daniel Carter 23/10/2026, 01:06 4 minutes to read